TXNIP and cancer: Across all scRNA-seq datasets available in TISCH (i.e. 78 datasets across 28 cancer types), TXNIP showed high expression levels in immune cells, fibroblasts and endothelial cells as well as malignant cells, irrespective of the cancer type (Figure 4).